StockWatch
·
Gems & Jewellery · BSE 514394 · Governance

Atlas Jewellery cannot approve Q2 results: all directors have ceased and a new board waits on NCLT Delhi

Every director has ceased, so no Board or Audit Committee can approve Q2 FY27 results by the Nov 15 deadline. An application before NCLT Delhi seeks appointment of new directors.

AJILAtlas Jewellery India Ltd11 Nov 2026 · 4 min read
Size tier

MICRO-CAP

by market cap ≈ ₹93.3 Cr

Directors on the Board

None

"cessation of all the directors" — Nov 11 filing

Q2 FY27 results deadline

Nov 15, 2026

Reg 33 — company says it cannot meet it

Promoter holding

95.82% 9,64,49,433 of 10.07 Cr shares (Jun 2026); the sole promoter has since died and the company reports no identifiable promoter at this point of time

Institutional holding

0%

FII and DII both nil (Jun 2026 pattern)

New directors

Before NCLT

Section 98 application, New Delhi Bench

At 12:54 IST on November 11, Atlas Jewellery India told BSE something few listed companies ever have to put in writing: it cannot approve its own quarterly results because it has no one left to approve them. The filing states that, due to cessation of all the directors in the recent past, the Board of Directors and the Audit Committee are no longer compliant with the Companies Act, 2013 and SEBI's Listing Regulations — and so the unaudited results for the quarter ended September 30, 2026, which Regulation 33 requires within forty-five days (on or before November 15, 2026), will not be approved in time.

What the filing says

No board, no audit committee, no results

governance

Atlas Jewellery intimates delay in Q2 FY27 results — all directors have ceased

The company informed BSE under Regulation 29 read with Regulation 33 of SEBI (LODR) Regulations, 2015 that the statutory meetings of the Board and Audit Committee to approve the unaudited standalone results for the quarter ended September 30, 2026 cannot be convened on or before November 15, 2026, because the cessation of all directors has left both bodies non-compliant with the Companies Act, 2013 and the Listing Regulations. An application under Section 98 of the Companies Act, 2013 is pending before the NCLT, New Delhi Bench for appointment of new director(s), and the company says it is awaiting the Tribunal's directions.

Read:The normal governance chain — audit committee review, board approval, exchange submission — cannot operate until a board exists. The filing also notes Regulation 33 has no provision for submitting provisional financial statements, so shareholders get no Q2 FY27 numbers at all until the NCLT acts and the Board and Audit Committee are duly reconstituted. The timing is not in the company's hands.

BSE filing, Nov 11, 2026 — Results-Delay in Financial Results

The mechanics matter here. Section 98 of the Companies Act, 2013 — the provision the company cites — is the route it has taken to the NCLT for the appointment of new director(s). Until the Tribunal gives directions, the filing says, the company will approve and announce the September-quarter results only once the Board and Audit Committee are duly constituted. There is no workaround in the rules the company points to: it states that Regulation 33 contains no provision for provisional financial statements.

The filing's own words
Due to cessation of all the directors in the recent past, the composition and structure of the Board of Directors and the Audit Committee of the Company has become imbalanced and not in compliance with the provisions of the Companies Act, 2013 and the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

— Atlas Jewellery India Ltd, BSE intimation, November 11, 2026

What this suggests — and this is inference, not something the filing states — is that the results delay is a symptom rather than the disease. The disease is a listed company operating with zero directors: no audit committee to review financials, no board to approve disclosures, no body to call a shareholder meeting. Holders of the roughly 4.18% of shares outside the promoter group (about 42.05 lakh of the 10.07 crore shares outstanding) have no audited or reviewed numbers coming, and no governance oversight, until the NCLT constitutes a new board.

The sequence

This was disclosed in stages, not all at once

  1. The date from which the company's trading window for designated persons has remained continuously closed, per its own September 30, 2026 intimation — to reopen only 48 hours after the Q2 FY27 results are announced.

  2. AGM deferment: the 36th AGM for FY 2025-26, required by September 30, 2026, is deferred. The company states it is "presently handicapped from calling any general meeting due to the non-existence of any director on the Board"; the same filing adds that, with the death of the sole promoter, the company has no identifiable promoter at this point of time. ROC Delhi has granted an extension.

  3. Trading window closure intimation for the September quarter — the window has stayed shut since March 31, 2022; the board meeting date for Q2 results "shall be intimated in due course".

  4. Routine compliance continues: certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 filed after market hours.

  5. Results-delay intimation: no compliant Board or Audit Committee exists; Section 98 application pending before NCLT, New Delhi Bench; Q2 FY27 results will miss the November 15 deadline.

The November 11 filing is therefore not the first notice of the vacancy — the September 28 AGM deferment had already recorded the non-existence of any director on the Board, and the same filing disclosed that the sole promoter had died, leaving the company with no identifiable promoter at this point of time; ROC Delhi had already granted an AGM extension. What the new filing adds is the consequence: a named statutory deadline (November 15) that will now pass without results, and confirmation that the fix runs through the NCLT rather than through any action the company can take itself. The trading-window detail is its own signal of how long the abnormality has run — by the company's September intimation, designated persons have been barred from trading since March 31, 2022, pending a results announcement that is still awaited.

The company on paper

A sub-₹1 crore revenue line, promoter-held almost entirely

Most recent quarterly results on record · standalone · ₹ crore
QuarterRevenueNet profit
Q3 FY220.78-0.03
Q2 FY220.26-0.58
Q1 FY220.471.5
Q4 FY210.380.63
Q3 FY210.44-1.82

Latest quarterly figures available on the exchange record; figures as stored in ₹ crore, rounded to two decimals.

The most recent quarterly numbers on record date to the December 2021 quarter — revenue of ₹0.78 crore and a marginal net loss of ₹0.03 crore — and none of the five quarters on record cleared ₹1 crore of revenue. Against that operating scale sits a market capitalisation of roughly ₹93.3 crore on 10.07 crore shares outstanding. The June 2026 shareholding pattern shows promoters at 95.82% with zero FII and zero DII holding; a subsequent filing discloses that the sole promoter has since died and the company now reports no identifiable promoter at this point of time — a structure where the entire institutional-oversight layer, and now the promoter itself, that might otherwise press for board reconstitution is simply absent.

What to watch

The filings that would change the picture

  • NCLT Delhi order

    Directions on the Section 98 application for appointment of new director(s) — the single gating event. Everything else waits on it.

  • Board reconstitution

    An intimation of newly appointed directors and a reconstituted Audit Committee compliant with the Companies Act, 2013 and the Listing Regulations.

  • Q2 FY27 results

    The company has said results follow once the Board and Audit Committee are duly constituted; their announcement would also reopen a trading window shut since March 31, 2022.

  • The deferred 36th AGM

    A date for the FY 2025-26 AGM, deferred under the ROC Delhi extension because no director existed to call it.

The November 11 intimation converts a governance vacancy that had been visible since at least the September 28 AGM deferment into a concrete, dated compliance failure: Q2 FY27 results will not arrive by November 15, and the company itself says it cannot fix that — only the NCLT's directions on the pending Section 98 application can restart the machinery of board meetings, audit-committee reviews and results approvals.

For the small free float outside the 95.82% holding formerly attributed to the sole promoter — who has since died, leaving the company with no identifiable promoter at this point of time — the practical position is an information blackout of uncertain duration in a micro-cap where the last quarterly results on record are from the December 2021 quarter. The filings to watch are procedural, not financial: an NCLT order, a board reconstitution, and only then a results date.

Informational and educational content only. Not investment advice.